<DOC>
	<DOCNO>NCT02284919</DOCNO>
	<brief_summary>In study , positron emission tomography ( PET/CT ) image use evaluate sigma-2 ( Ïƒ2 ) receptor activity sit primary breast cancer use investigational radiotracer [ 18F ] ISO-1 .</brief_summary>
	<brief_title>18FISO-1 PET/CT Breast Cancer</brief_title>
	<detailed_description>This study evaluate feasibility use [ 18F ] ISO-1 PET/CT image sigma-2 receptor bind primary breast tumor continue evaluate safety tracer patient population . [ 18F ] ISO-1 uptake measure correlate qualitative immunohistochemical staining cell proliferation ( Ki67 ) . This observational study [ 18F ] ISO-1 PET/CT use direct treatment decision .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>1 . Adult patient , least 18 year age 2 . Known suspected breast cancer least one breast lesion 1 cm great size standard imaging ( e.g . mammography , ultrasound breast MRI ) 3 . Participants must inform investigational nature study provide write informed consent accordance institutional federal guideline prior studyspecific procedure 1 . Females pregnant time screen eligible study , urine serum pregnancy test perform woman childbearing potential time screen . 2 . Inability tolerate image procedure opinion investigator treat physician 3 . Serious unstable medical psychological condition , opinion investigator , would compromise subject 's safety successful participation study . 4 . Unwilling unable provide inform consent .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>